Literature DB >> 4717034

Whole blood 5 -hydroxytryptamine during treatment of endogenous depressive illness.

J J Gayford, A L Parker, E M Phillips, A R Rowsell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4717034     DOI： 10.1192/bjp.122.5.597

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN： 0007-1250            Impact factor:   9.319


× No keyword cloud information.
  4 in total

1.  Inhibition of 5-hydroxytryptamine uptake in human platelets by antidepressant agents in vivo.

Authors:  S B Ross; B Aperia; J Beck-Friis; S Jansa; L Wetterberg; A Aberg
Journal:  Psychopharmacology (Berl)       Date:  1980-01       Impact factor: 4.530

2.  Ect and platelet 5ht uptake in major depression.

Authors:  P K Dalal; N Lal; J K Trivedi; P K Seth; A K Agarwal; A Khalid
Journal:  Indian J Psychiatry       Date:  1997-10       Impact factor: 1.759

3.  Active platelet 5-ht uptake in depressives treated with impramine and ect.

Authors:  P K Dalal; N Lal; J K Trivedi; P K Seth; A K Agarwal; A Khalid
Journal:  Indian J Psychiatry       Date:  1998-01       Impact factor: 1.759

4.  Blood noradrenaline and 5-HT levels in depressed women during amitriptyline or lithium treatment.

Authors:  G L Corona; M L Cucchi; G Santagostino; P Frattini; F Zerbi; L Fenoglio; F Savoldi
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.